Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2025-12-26 @ 3:18 AM
Study NCT ID:
NCT04987320
Status:
COMPLETED
Last Update Posted:
2025-02-10
First Post:
2021-07-26
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Olpasiran in Chinese Participants With Elevated Serum Lipoprotein(a)
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-28
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-18
Completion Date Type:
ACTUAL
First Submit Date:
2021-07-26
First Submit QC Date:
None
Study First Post Date:
2021-08-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-11-08
Results First Submit QC Date:
None
Results First Post Date:
2025-02-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-20
Last Update Post Date:
2025-02-10
Last Update Post Date Type:
ACTUAL